Central Trust Company’s Novanta NOVT Stock Holding History

Central Trust Company’s Portfolio NOVT Stock Details NOVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.25K	Sell	20 -34	-63%	-$4.92K	﹤0.01%	1365
2026 Q1	$6.38K	Buy	54 +14	+35%	+$1.84K	﹤0.01%	1226
2025 Q4	$4.76K	Buy	40 +10	+33%	+$1.14K	﹤0.01%	1239
2025 Q3	$3K	Hold	30	–	–	﹤0.01%	1255
2025 Q2	$3.87K	Hold	30	–	–	﹤0.01%	1244
2025 Q1	$3.84K	Hold	30	–	–	﹤0.01%	1244
2024 Q4	$4.58K	Hold	30	–	–	﹤0.01%	1210
2024 Q3	$5.37K	Hold	30	–	–	﹤0.01%	1145
2024 Q2	$4.89K	Hold	30	–	–	﹤0.01%	1178
2024 Q1	$5.24K	Hold	30	–	–	﹤0.01%	1167
2023 Q4	$5.05K	Hold	30	–	–	﹤0.01%	1160
2023 Q3	$4.3K	Buy	+30	New	+$4.89K	﹤0.01%	1152

Other funds holding NOVT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Central Trust Company's NOVT Position: Q2 2026 in Review

Central Trust Company reduced its Novanta (NOVT) stake by 63% in Q2 2026, selling an estimated $4.92K and leaving 20 shares worth $3.25K. The position accounts for ﹤0.01% of the portfolio, ranked #1365.

Central Trust Company first reported a position in NOVT in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.38K in Q1 2026. 389 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

Central Trust Company held 20 shares of Novanta worth $3.25K as of Q2 2026.
Central Trust Company sold 34 Novanta shares in Q2 2026, an estimated $4.92K.
Novanta made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #1365 holding.
Central Trust Company first reported a position in Novanta in Q3 2023 and has held it in 12 quarters since.
Central Trust Company's Novanta position peaked at $6.38K in Q1 2026.
389 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.